Galecto Stock (NASDAQ: GLTO) stock price, news, charts, stock research, profile.
You can purchase shares of Galecto (NASDAQ:GLTO) through any online brokerage.
Other companies in Galecto’s space includes: Vincerx Pharma (NASDAQ:VINC), Syros Pharmaceuticals (NASDAQ:SYRS), Alzamend Neuro (NASDAQ:ALZN), T2 Biosystems (NASDAQ:TTOO) and Coeptis Therapeutics (NASDAQ:COEP).
Galecto has a consensus price target of $8.50.
The stock price for Galecto (NASDAQ: GLTO) is $4.94 last updated December 24, 2024 at 4:53 AM EST.
There are no upcoming dividends for Galecto.
Galecto’s Q4 earnings are confirmed for Friday, March 7, 2025.
There is no upcoming split for Galecto.
Galecto is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.